EDAP TMS S.A (EDA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EDAP TMS S.A (EDA) has a cash flow conversion efficiency ratio of -0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.78 Million ≈ $-2.08 Million USD) by net assets (€19.41 Million ≈ $22.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EDAP TMS S.A balance sheet independence to measure how much of total assets are equity-financed.
EDAP TMS S.A - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how EDAP TMS S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EDA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
EDAP TMS S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EDAP TMS S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zinus Inc
KO:013890
|
-0.008x |
|
Nynomic AG
F:M7U
|
-0.045x |
|
Cosmax
KO:044820
|
0.059x |
|
Mercator Medical S.A.
WAR:MRC
|
0.052x |
|
Alkindo Naratama Tbk
JK:ALDO
|
-0.038x |
|
ParTec AG
XETRA:JY0
|
N/A |
|
Plby Group Inc
NASDAQ:PLBY
|
-0.242x |
|
RF Materials Co. Ltd
KQ:327260
|
0.014x |
Annual Cash Flow Conversion Efficiency for EDAP TMS S.A (2016–2025)
The table below shows the annual cash flow conversion efficiency of EDAP TMS S.A from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see EDAP TMS S.A (EDA) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €19.41 Million ≈ $22.70 Million |
€-16.41 Million ≈ $-19.18 Million |
-0.845x | -154.47% |
| 2024-12-31 | €40.90 Million ≈ $47.81 Million |
€-13.58 Million ≈ $-15.88 Million |
-0.332x | -28.82% |
| 2023-12-31 | €56.92 Million ≈ $66.55 Million |
€-14.68 Million ≈ $-17.16 Million |
-0.258x | -510.81% |
| 2022-12-31 | €71.63 Million ≈ $83.75 Million |
€-3.02 Million ≈ $-3.54 Million |
-0.042x | -147.54% |
| 2021-12-31 | €50.05 Million ≈ $58.52 Million |
€4.45 Million ≈ $5.20 Million |
0.089x | +17.90% |
| 2020-12-31 | €26.25 Million ≈ $30.69 Million |
€1.98 Million ≈ $2.31 Million |
0.075x | -45.77% |
| 2019-12-31 | €27.36 Million ≈ $31.98 Million |
€3.80 Million ≈ $4.44 Million |
0.139x | +1881.41% |
| 2018-12-31 | €24.96 Million ≈ $29.19 Million |
€175.00K ≈ $204.59K |
0.007x | +105.77% |
| 2017-12-31 | €25.16 Million ≈ $29.41 Million |
€-3.06 Million ≈ $-3.58 Million |
-0.122x | -345.91% |
| 2016-12-31 | €24.45 Million ≈ $28.59 Million |
€1.21 Million ≈ $1.41 Million |
0.049x | -- |
About EDAP TMS S.A
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more